Patents by Inventor Ursula Habenicht

Ursula Habenicht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition containing an androgenous 11b-halogen steroid and a progestational hormone, and male contraceptive based on said composition
    Publication number: 20060100180
    Abstract: The invention relates to a novel chemical composition containing an androgenous 11?-halogen steroid and the progestational hormone of formula (I), to a pharmaceutical composition containing said chemical composition and to a male contraceptive based on said pharmaceutical composition.
    Type: Application
    Filed: July 25, 2003
    Publication date: May 11, 2006
    Inventors: Reinhard Nubbemeyer, Ursula Habenicht, Rolf Bohlmann
  • Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
    Patent number: 6696432
    Abstract: The present invention concerns the combination of dehydroepiandrosterone (DHEA) and at least one aromatase inhibitor and the use of such a combination to produce a medicament for treating relative and/or absolute androgen deficiency in men. Selective aromatase inhibitors such as atamestan, formestan, pentrozol, aramidex, fadrozol, CGS 20267 and/or vorozol, are preferred for producing the medicament according to the invention.
    Type: Grant
    Filed: November 3, 1998
    Date of Patent: February 24, 2004
    Assignee: Schering Aktiengesellschaft
    Inventors: Jörg Elliesen, Albert Radlmaier, Ursula Habenicht, Friedmund Neumann
  • Peptide compounds, in particular LHRH-antagonists
    Patent number: 5527777
    Abstract: The invention concerns LHRH antagonists of the general formula (I),X-X.sub.1 -X.sub.2 -X.sub.3 -L-Ser-L-Tyr-X.sub.6 -L-Leu-X.sub.8 -L-Pro-X.sub.10 (I)The invention concerns LHRH antagonists of the general formula (I), in which X is an acyl group, X.sub.1 is a D-Nal, X.sub.2 is D-(4-Cl)-Phe, X.sub.3 is D-(3)-Pal, X.sub.6 is D-Cit or D-Neu, X.sub.8 is L-Arg or L-Neu, at least one of the groups X.sub.6 and X.sub.8 being a Neu, and X.sub.10 is D-Ala-NH.sub.2, Neu being a group of formula (II), (IV), (IX) or (X), wherein W is one of the group (a)-(d). The invention includes drugs containing a compound of formula (I), plus the usual auxiliaries and carriers. These drugs are suitable for use in cases of carcinoma of the prostate and in endometriosis, as well as for fertility control.
    Type: Grant
    Filed: May 4, 1994
    Date of Patent: June 18, 1996
    Assignee: Schering Aktiengesellschaft
    Inventors: Paul Thamm, Alessandro Lobbia, Thomas Brumby, Johann Mulzer, Fridtjog Schroder, Ursula Habenicht
  • Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids
    Patent number: 5389624
    Abstract: [3,2-c]Pyrazole and [3,2-d]triazole steroids are useful anti-androgens.
    Type: Grant
    Filed: April 27, 1993
    Date of Patent: February 14, 1995
    Assignee: Schering Aktiengesellschaft
    Inventors: Helmut Hofmeister, Dieter Bittler, Horst Michna, Ursula Habenicht, Karl-Heinrich Fritzemeier, Yukishige Nishino
  • Antiandrogenic [3,2-c]pyrazole and [3,2-d]triazole steroids
    Patent number: 5236912
    Abstract: [3,2-c]Pyrazole and [3,2-d]triazole steroids are useful anti-androgens.
    Type: Grant
    Filed: July 5, 1991
    Date of Patent: August 17, 1993
    Assignee: Schering Aktiengesellschaft
    Inventors: Helmut Hofmeister, Dieter Bittler, Horst Michna, Ursula Habenicht, Karl-Heinrich Fritzemeier, Yukishige Nishino